These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37886843)

  • 1. Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART).
    Grant-McAuley W; Piwowar-Manning E; Clarke W; Breaud A; Zewdie KB; Moore A; Ayles HM; Kosloff B; Shanaube K; Bock P; Meehan SA; Maarman G; Fidler S; Hayes R; Donnell D; Eshleman SH;
    J Int AIDS Soc; 2023 Oct; 26(10):e26179. PubMed ID: 37886843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural control of HIV infection in young women in South Africa: HPTN 068.
    Sivay MV; Fogel JM; Wang J; Zhang Y; Piwowar-Manning E; Clarke W; Breaud A; Blankson J; Hamilton EL; Kahn K; Selin A; Gomez-Olive FX; MacPhail C; Hughes JP; Pettifor A; Eshleman SH
    HIV Clin Trials; 2018 Oct; 19(5):202-208. PubMed ID: 30522410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of antibody targets associated with lower HIV viral load and viremic control.
    Grant-McAuley W; Morgenlander WR; Ruczinski I; Kammers K; Laeyendecker O; Hudelson SE; Thakar M; Piwowar-Manning E; Clarke W; Breaud A; Ayles H; Bock P; Moore A; Kosloff B; Shanaube K; Meehan SA; van Deventer A; Fidler S; Hayes R; Larman HB; Eshleman SH;
    PLoS One; 2024; 19(9):e0305976. PubMed ID: 39288118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART).
    Fogel JM; Wilson EA; Piwowar-Manning E; Breaud A; Clarke W; Petropoulos C; Moore A; Fraser C; Kosloff B; Shanaube K; van Zyl G; Scheepers M; Floyd S; Bock P; Ayles H; Fidler S; Hayes R; Donnell D; Eshleman SH;
    J Int AIDS Soc; 2022 Jul; 25(7):e25941. PubMed ID: 35775502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.
    Vermund SH; Fidler SJ; Ayles H; Beyers N; Hayes RJ
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S221-7. PubMed ID: 23764639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    Hayes R; Floyd S; Schaap A; Shanaube K; Bock P; Sabapathy K; Griffith S; Donnell D; Piwowar-Manning E; El-Sadr W; Beyers N; Ayles H; Fidler S;
    PLoS Med; 2017 May; 14(5):e1002292. PubMed ID: 28464041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load.
    Grant-McAuley W; Morgenlander W; Hudelson SE; Thakar M; Piwowar-Manning E; Clarke W; Breaud A; Blankson J; Wilson E; Ayles H; Bock P; Moore A; Kosloff B; Shanaube K; Meehan SA; van Deventer A; Fidler S; Hayes R; Ruczinski I; Kammers K; Laeyendecker O; Larman HB; Eshleman SH
    Front Immunol; 2023; 14():1178520. PubMed ID: 37744365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
    Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
    PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.
    Thomas R; Burger R; Harper A; Kanema S; Mwenge L; Vanqa N; Bell-Mandla N; Smith PC; Floyd S; Bock P; Ayles H; Beyers N; Donnell D; Fidler S; Hayes R; Hauck K;
    Lancet Glob Health; 2017 Nov; 5(11):e1133-e1141. PubMed ID: 28964756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
    Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
    Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).
    Hayes RJ; Donnell D; Floyd S; Mandla N; Bwalya J; Sabapathy K; Yang B; Phiri M; Schaap A; Eshleman SH; Piwowar-Manning E; Kosloff B; James A; Skalland T; Wilson E; Emel L; Macleod D; Dunbar R; Simwinga M; Makola N; Bond V; Hoddinott G; Moore A; Griffith S; Deshmane Sista N; Vermund SH; El-Sadr W; Burns DN; Hargreaves JR; Hauck K; Fraser C; Shanaube K; Bock P; Beyers N; Ayles H; Fidler S;
    N Engl J Med; 2019 Jul; 381(3):207-218. PubMed ID: 31314965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.
    Wilson E; Donnell D; Skalland T; Floyd S; Moore A; Bell-Mandla N; Bwalya J; Kasese N; Dunbar R; Shanaube K; Kosloff B; Laeyendecker O; Agyei Y; Hoddinott G; Bock P; Fidler S; Hayes R; Ayles H;
    Lancet HIV; 2022 Nov; 9(11):e760-e770. PubMed ID: 36332653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.
    Macleod D; Shanaube K; Skalland T; Limbada M; Mandla N; Bwalya J; Schaap A; Yang B; Donnell D; Piwowar-Manning E; Eshleman SH; Hoddinott G; Bond V; Moore A; Griffith S; Bock P; Ayles H; Fidler S; Hayes R; Floyd S;
    Lancet HIV; 2022 Nov; 9(11):e751-e759. PubMed ID: 36332652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART).
    Eshleman SH; Piwowar-Manning E; Wilson EA; Lennon D; Fogel JM; Agyei Y; Sullivan PA; Weng L; Moore A; Laeyendecker O; Kosloff B; Bwalya J; Maarman G; van Deventer A; Floyd S; Bock P; Ayles H; Fidler S; Hayes R; Donnell D;
    J Int AIDS Soc; 2020 Feb; 23(2):e25452. PubMed ID: 32072743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068.
    Zhang Y; Sivay MV; Hudelson SE; Clarke W; Breaud A; Wang J; Piwowar-Manning E; Agyei Y; Fogel JM; Hamilton EL; Selin A; MacPhail C; Kahn K; Gómez-Olivé FX; Hughes JP; Pettifor A; Eshleman SH
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):315-322. PubMed ID: 29985265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The difference that makes a difference": highlighting the role of variable contexts within an HIV Prevention Community Randomised Trial (HPTN 071/PopART) in 21 study communities in Zambia and South Africa.
    Bond V; Chiti B; Hoddinott G; Reynolds L; Schaap A; Simuyaba M; Ndubani R; Viljoen L; Simwinga M; Fidler S; Hayes R; Ayles H; Seeley J;
    AIDS Care; 2016; 28 Suppl 3():99-107. PubMed ID: 27421057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa.
    Hargreaves JR; Stangl A; Bond V; Hoddinott G; Krishnaratne S; Mathema H; Moyo M; Viljoen L; Brady L; Sievwright K; Horn L; Sabapathy K; Ayles H; Beyers N; Bock P; Fidler S; Griffith S; Seeley J; Hayes R;
    Health Policy Plan; 2016 Dec; 31(10):1342-1354. PubMed ID: 27375126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa.
    Jones HS; Floyd S; Stangl A; Bond V; Hoddinott G; Pliakas T; Bwalya J; Mandla N; Moore A; Donnell D; Bock P; Fidler S; Hayes R; Ayles H; Hargreaves JR;
    Trop Med Int Health; 2020 Oct; 25(10):1246-1260. PubMed ID: 32745296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART).
    Fogel JM; Zewdie K; Clarke WA; Piwowar-Manning E; Breaud A; Moore A; Kosloff B; Shanaube K; van Zyl G; Scheepers M; Floyd S; Bock P; Ayles H; Fidler S; Hayes R; Donnell D; Eshleman SH;
    Open Forum Infect Dis; 2022 Nov; 9(11):ofac576. PubMed ID: 36447611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.